Hong Kong’s Centre for Health Protection (CHP) is investigating a case of potential botulism after a 38-year-old woman received unauthorized botulinum toxin injections in Dongguan, on the Chinese mainland.
The patient, who was previously in good health, received injections from an unverified source on October 27. Unable to confirm the practitioner’s professional qualifications, she soon developed alarming symptoms including limb weakness, swallowing difficulties, and partial eyelid drooping. After initially seeking medical attention in Dongguan on November 3, she was later admitted to North District Hospital in Hong Kong on November 8, where her condition remains stable but under close medical supervision.
CHP has reported the case to mainland authorities and is conducting epidemiological investigations.
“In Hong Kong, botulinum toxin injections should only be performed by a locally registered doctor. Customers should verify the doctor’s full name against the list of registered doctors of the Medical Council of Hong Kong as well as their professional qualifications and relevant experience. When receiving injections outside Hong Kong, pay special attention to ensure the provider is qualified or registered with relevant jurisdictions for practice. In case of injections offered from suspicious sources, refrain from receiving them. If feeling unwell, seek medical advice from eligible medical professionals as soon as possible,” said a spokesperson for the Department of Health.
Health officials have strongly advised the public to take multiple precautions before receiving any botulinum toxin treatments:
1. Verify the practitioner’s medical registration and professional credentials
2. Understand the complete procedure and potential medical risks
3. Avoid treatments from unverified or suspicious sources
4. Disclose any medical history that might contraindicate the procedure
5. Request written documentation of the doctor’s professional qualifications
6. Seek immediate medical attention if any concerning symptoms develop
Food Poisoning News has reported on multiple incidents of botulism this year from counterfeit or unlicensed botox injections. In June, another Hong Kong woman was critically injured after receiving unlicensed injections also in mainland China. A month later, seven women in New York and Tennessee were sickened from counterfeit botox injections.
Commenting on this article, one national botulism lawyer said, “This story is a reminder that cosmetic procedures, while seemingly routine, involve significant medical risks. Safety should be top of mind for all consumers so they make informed decisions. It is important to verify professional credentials and understand potential complications before undergoing any medical treatment.”
